In summary, we demonstrated that the glucose transporter GLUT1 was overexpressed in patient-derived human GBM tissue and its overexpression correlated with poor prognosis upon examination utilizing data mining of The Cancer Genome Atlas. The gene discussed is SLC2A1; the disease is glioblastoma.